Literature DB >> 670383

Oligomeric immunoglobulin A antibody response to rubella virus infection.

S Inouye, R Kono, Y Takeuchi.   

Abstract

Pooled sera from rubella patients in the early convalescent stage, containing a high titer of hemagglutination-inhibiting (HI) antibody, were treated with protein A-conjugated gel to reduce immunoglobulin G (IgG) antibody and then centrifuged in sucrose gradients. This treatment resulted in the detection of an HI activity peak sedimenting at a rate intermediate between 7S and 19S. In contrast to the 19S antibody, the HI activity of this peak was not abolished by 2-mercaptoethanol, but sedimented at 7S after this treatment. The activity was considered to consist of IgA oligomers, since it was removed by anti-IgA immunosorbent. The appearance of the oligomeric IgA antibody after the infection was then studied using serum samples collected sequentially from five rubella patients. Shortly after the onset of the disease, the HI activity appeared at high titer and thereafter gradually decreased in titer until it could no longer be detected in the sera. The time of its disappearance varied with each patient.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 670383      PMCID: PMC275104          DOI: 10.1128/jcm.8.1.1-6.1978

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Rubellavirus-specific IgM- and IgA-antibodies. The indirect immunofluorescence (IF)-technique applied to sera with reduced IgG-concentration.

Authors:  A Hornsleth; J Leerhoy; P Grauballe; H Spanggaard
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-10

2.  Rubella: a method for rapid diagnosis of a recent infection by demonstration of the IgM antibodies.

Authors:  T Vesikari; A Vaheri
Journal:  Br Med J       Date:  1968-01-27

3.  A rountine diagnostic test for IgA and IgM antibodies to rubella virus: absorption of IgG with Staphylococcus aureus.

Authors:  J Ankerst; P Christensen; L Kjellén; G Kronvall
Journal:  J Infect Dis       Date:  1974-09       Impact factor: 5.226

4.  Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.

Authors:  P L Ogra; D Kerr-Grant; G Umana; J Dzierba; D Weintraub
Journal:  N Engl J Med       Date:  1971-12-09       Impact factor: 91.245

5.  Specific response of the immunoglobulins to rubella infection.

Authors:  J V Baublis; G C Brown
Journal:  Proc Soc Exp Biol Med       Date:  1968-05

6.  Persistence of rubellavirus-specific immunoglobulin M and immunoglobulin A antibodies: investigation of successive serum samples with lowered immunoglobulin G concentration.

Authors:  A Hornsleth; J Leerhoy; P Grauballe; H Spanggaard
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

7.  Persistence of specific IgM after natural infection with rubella virus.

Authors:  J R Pattison
Journal:  Lancet       Date:  1975-01-25       Impact factor: 79.321

8.  Letter: Rubella-specific IgM and a new inhibitor.

Authors:  W al-Nakib; J M Best; J E Banatvala
Journal:  Br Med J       Date:  1974-08-31

9.  Distribution of echovirus antibody in serum, nasopharynx, rectum, and spinal fluid after natural infection with echovirus type 6.

Authors:  P L Ogra
Journal:  Infect Immun       Date:  1970-08       Impact factor: 3.441

10.  Separation of rubella IgM, IgA, and IgG antibodies by gel filtration on agarose.

Authors:  A Bürgin-Wolff; R Hernandez; M Just
Journal:  Lancet       Date:  1971-12-11       Impact factor: 79.321

View more
  13 in total

1.  Detection of rubella virus-specific polymeric immunoglobulin A by enzyme-linked immunosorbent assay in combination with streptococcal pretreatment of serum.

Authors:  K Kawano; Y Minamishima
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

Review 2.  Rubella vaccines: past, present and future.

Authors:  J M Best
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

3.  Differentiation of primary from nonprimary genital herpesvirus infections by detection of polymeric immunoglobulin A activity.

Authors:  M Hashido; T Kawana; S Inouye
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

4.  Complement-fixing immunoglobulin M antibody response in patients with infantile gastroenteritis.

Authors:  Y Abe; S Inouye
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

5.  Single-serum diagnosis of rubella by combined use of the hemagglutination inhibition and passive hemagglutination tests.

Authors:  S Inouye; K Satoh; T Tajima
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

6.  Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed.

Authors:  S Inouye; A Hasegawa; S Matsuno; S Katow
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

7.  Efficient coating of the solid phase with rotavirus antigens for enzyme-linked immunosorbent assay of immunoglobulin A antibody in feces.

Authors:  S Inouye; S Matsuno; H Yamaguchi
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

8.  Removal of nonspecific hemagglutination inhibitors, immunoglobulin G, and immunoglobulin A with streptococcal cells and its application to the rubella hemagglutination inhibition test.

Authors:  K Kawano; Y Minamishima
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

9.  Experimental infection of young rabbits with rabbit parvovirus.

Authors:  Y Matsunaga; F Chino
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

10.  Evaluation of single whole inclusion serum test for IgG antibody to Chlamydia trachomatis in asymptomatic women.

Authors:  M P Meyer; A J Amortegui
Journal:  Genitourin Med       Date:  1987-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.